Correlation Between Cardio Diagnostics and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Denali Therapeutics, you can compare the effects of market volatilities on Cardio Diagnostics and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Denali Therapeutics.
Diversification Opportunities for Cardio Diagnostics and Denali Therapeutics
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cardio and Denali is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Denali Therapeutics
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 3.58 times more return on investment than Denali Therapeutics. However, Cardio Diagnostics is 3.58 times more volatile than Denali Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Denali Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 30.00 in Cardio Diagnostics Holdings on December 2, 2024 and sell it today you would earn a total of 15.00 from holding Cardio Diagnostics Holdings or generate 50.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Denali Therapeutics
Performance |
Timeline |
Cardio Diagnostics |
Denali Therapeutics |
Cardio Diagnostics and Denali Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Denali Therapeutics
The main advantage of trading using opposite Cardio Diagnostics and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Denali Therapeutics vs. Stoke Therapeutics | Denali Therapeutics vs. Black Diamond Therapeutics | Denali Therapeutics vs. 4D Molecular Therapeutics | Denali Therapeutics vs. Ascendis Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |